Pure Global

Natural History and Risk Factors of TAO - Trial NCT03515863

Access comprehensive clinical trial information for NCT03515863 through Pure Global AI's free database. This phase not specified trial is sponsored by Sun Yat-sen University and is currently status unknown. The study focuses on Thyroid Associated Ophthalmopathy. Target enrollment is 400 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT03515863
genetic
Trial Details
ClinicalTrials.gov โ€ข NCT03515863
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Natural History and Risk Factors of TAO
Natural History and Genetic Risk Factors of Thyroid Associated Ophthalmopathy (TAO)

Study Focus

DNA extraction and genetic characterization

Observational

genetic

Sponsor & Location

Sun Yat-sen University

Guangzhou,Zhaoqing, China

Timeline & Enrollment

N/A

May 15, 2018

May 09, 2022

400 participants

Primary Outcome

Genetic risk factors of TAO predisposition

Summary

The aim of this study is to complete the identification of genetic factors predisposing to
 thyroid associated ophthalmopathy (TAO) by constituting a cohort of 400 Grave's patients with
 or without ocular signs.

ICD-10 Classifications

Thyroiditis
Disorders of thyroid gland
Thyroiditis, unspecified
Other disorders of thyroid
Disorder of thyroid, unspecified

Data Source

ClinicalTrials.gov

NCT03515863

Non-Device Trial